Allow flexibility with portion controlled treats to avoid rigid restriction
*The following information, as well as all statements and products on this website, have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition
Advantage : Neither (tie) Type 2 Diabetes Efficacy# CagriSema : REDEFINE 2 showed 13.7% weight loss and 73.5% of T2D patients achieving HbA1c of 6.5% or less at 68 weeks
Market-wide, monthly totals commonly range from roughly $200 to $700 or more as of April 2026, so a single advertised number rarely captures the full cost
By facilitating considerable weight loss, these medications can enable patients to make the necessary lifestyle adjustments for a healthier life
Understanding the differences between semaglutide and tirzepatide can help you make more informed decisions about your health and treatment options